Oragenics (OGEN) Competitors $1.47 -0.08 (-5.16%) Closing price 03:59 PM EasternExtended Trading$1.46 0.00 (-0.34%) As of 04:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock OGEN vs. EVOK, TTNP, CMND, VIVS, VAXX, PLRZ, LIPO, INM, CERO, and CANFShould you be buying Oragenics stock or one of its competitors? The main competitors of Oragenics include Evoke Pharma (EVOK), Titan Pharmaceuticals (TTNP), Clearmind Medicine (CMND), VivoSim Labs (VIVS), Vaxxinity (VAXX), Polyrizon (PLRZ), Lipella Pharmaceuticals (LIPO), InMed Pharmaceuticals (INM), CERo Therapeutics (CERO), and Can-Fite BioPharma (CANF). These companies are all part of the "pharmaceutical products" industry. Oragenics vs. Its Competitors Evoke Pharma Titan Pharmaceuticals Clearmind Medicine VivoSim Labs Vaxxinity Polyrizon Lipella Pharmaceuticals InMed Pharmaceuticals CERo Therapeutics Can-Fite BioPharma Evoke Pharma (NASDAQ:EVOK) and Oragenics (NYSE:OGEN) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their media sentiment, earnings, dividends, valuation, institutional ownership, profitability, risk and analyst recommendations. Do institutionals & insiders believe in EVOK or OGEN? 18.7% of Oragenics shares are owned by institutional investors. 6.1% of Evoke Pharma shares are owned by company insiders. Comparatively, 4.9% of Oragenics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has better valuation and earnings, EVOK or OGEN? Evoke Pharma has higher revenue and earnings than Oragenics. Evoke Pharma is trading at a lower price-to-earnings ratio than Oragenics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEvoke Pharma$10.25M0.39-$5.35M-$2.87-0.94Oragenics$40K26.28-$20.66M-$33.63-0.04 Which has more volatility & risk, EVOK or OGEN? Evoke Pharma has a beta of -0.04, indicating that its stock price is 104% less volatile than the S&P 500. Comparatively, Oragenics has a beta of 0.94, indicating that its stock price is 6% less volatile than the S&P 500. Is EVOK or OGEN more profitable? Oragenics has a net margin of 0.00% compared to Evoke Pharma's net margin of -43.80%. Evoke Pharma's return on equity of -101.91% beat Oragenics' return on equity.Company Net Margins Return on Equity Return on Assets Evoke Pharma-43.80% -101.91% -33.75% Oragenics N/A -2,087.95%-486.56% Does the media refer more to EVOK or OGEN? In the previous week, Evoke Pharma and Evoke Pharma both had 2 articles in the media. Evoke Pharma's average media sentiment score of 1.31 beat Oragenics' score of 0.20 indicating that Evoke Pharma is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Evoke Pharma 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Oragenics 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryEvoke Pharma beats Oragenics on 7 of the 12 factors compared between the two stocks. Get Oragenics News Delivered to You Automatically Sign up to receive the latest news and ratings for OGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OGEN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OGEN vs. The Competition Export to ExcelMetricOragenicsPharmaceutical IndustryMedical SectorNYSE ExchangeMarket Cap$1.05M$783.08M$5.49B$20.51BDividend YieldN/A4.84%5.38%3.76%P/E Ratio-0.211.2926.2027.81Price / Sales26.28219.44415.5037.44Price / CashN/A23.4436.4921.79Price / Book2.416.008.054.55Net Income-$20.66M-$27.64M$3.15B$984.47M7 Day Performance-57.51%-0.31%1.92%3.57%1 Month Performance-70.66%6.60%4.90%6.03%1 Year Performance-95.20%9.46%35.95%14.48% Oragenics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OGENOragenics0.0465 of 5 stars$1.47-5.2%N/A-95.1%$1.05M$40K-0.215News CoverageGap DownHigh Trading VolumeEVOKEvoke Pharma1.1965 of 5 stars$2.71+1.7%N/A-53.1%$4.03M$10.25M-0.944Positive NewsTTNPTitan Pharmaceuticals0.3164 of 5 stars$4.31+1.2%N/A-21.9%$3.92M$180K-0.9410CMNDClearmind Medicine0.5768 of 5 stars$0.89+2.3%N/A-47.5%$3.81MN/A-0.81N/AVIVSVivoSim LabsN/A$1.47+1.0%N/AN/A$3.81M$140K-0.1420Positive NewsVAXXVaxxinityN/A$0.03+29,900.0%N/A-100.0%$3.80MN/A-0.0790PLRZPolyrizonN/A$0.71-1.7%N/AN/A$3.79MN/A0.00N/APositive NewsGap DownLIPOLipella Pharmaceuticals2.006 of 5 stars$0.84flatN/A-77.0%$3.75M$536.36K-0.214INMInMed Pharmaceuticals0.9891 of 5 stars$3.02-2.3%N/A-38.6%$3.66M$4.60M-0.2510Gap DownCEROCERo Therapeutics3.6709 of 5 stars$9.37+1.6%$45.00+380.1%-98.3%$3.66MN/A0.008CANFCan-Fite BioPharma2.6434 of 5 stars$1.03-0.9%$14.00+1,257.9%-60.2%$3.65M$674K-0.588Gap Down Related Companies and Tools Related Companies Evoke Pharma Competitors Titan Pharmaceuticals Competitors Clearmind Medicine Competitors VivoSim Labs Competitors Vaxxinity Competitors Polyrizon Competitors Lipella Pharmaceuticals Competitors InMed Pharmaceuticals Competitors CERo Therapeutics Competitors Can-Fite BioPharma Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:OGEN) was last updated on 7/2/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored“E.I.”- The biggest prediction of my career?One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | Sponsored379 passengers walked away from thisElon Musk just wrote a $51 million check to back this material’s next phase… Because it’s not just saving l...True Market Insiders | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oragenics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oragenics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
